HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

potassium phosphate (potassium dihydrogen phosphate)

Subscribe to New Research on potassium phosphate

used in dental materials and to treat hypophosphatemia; RN given refers to cpd with unspecified MF

Also Known As:

potassium dihydrogen phosphate; dipotassium hydrogen phosphate; potassium monohydrogen phosphate; K2HPO4; KD2PO4; potassium acid phosphate; potassium dideuterium phosphate; potassium phosphate (K-H2PO4); potassium phosphate (K-H3PO4(1:2)); potassium phosphate (K2-HPO4); potassium phosphate (K3-PO4); potassium phosphate, dibasic; potassium phosphate, monobasic; Phosphoric acid, monopotassium salt

Networked: 115 relevant articles (7 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Inorganic Chemicals: 9

Experts

1.	Huang, Wenhai: 2 articles (02/2010 - 05/2009)
2.	Rahaman, Mohamed N: 2 articles (02/2010 - 05/2009)
3.	Mora, D: 2 articles (01/2003 - 01/2002)
4.	Miwa, Kenta: 1 article (12/2015)
5.	Ichikawa, Hajime: 1 article (12/2015)
6.	Matsutomo, Norikazu: 1 article (12/2015)
7.	Shimada, Hideki: 1 article (12/2015)
8.	Watanabe, Yoichi: 1 article (12/2015)
9.	Kato, Toyohiro: 1 article (12/2015)
10.	Scott, R: 1 article (03/2015)

Related Diseases

1.	Hypophosphatemia 08/01/2003 - "Patients with severe hypophosphatemia (<0.40 mmol/l; n=10) were also randomized into two groups: group 3 received 45 mmol potassium phosphate intravenously in 100 ml saline over 3 h, and group 4 received 45 mmol potassium phosphate in 100 ml saline over 6 h. " 08/01/2003 - "Patients with moderate hypophosphatemia (<0.65 and >0.40 mmol/l; n=37) were randomized into two groups: group 1 received 30 mmol potassium phosphate intravenously in 50 ml saline over 2 h, and group 2 received 30 mmol potassium phosphate in 100 ml saline over 4 h. " 08/01/2003 - "To evaluate efficacy and safety of aggressive correction of hypophosphatemia with intravenous potassium phosphate in the ICU. " 09/01/1993 - "Intravenous potassium phosphate administration corrected the hypophosphatemia in four of five cats. " 06/01/1997 - "The administration of potassium phosphate 15 mmol to critically ill patients with mild-to-moderate hypophosphatemia over 3 hours is both effective and safe. "
2.	Critical Illness (Critically Ill) 06/01/1997 - "To evaluate the efficacy and safety of intravenous potassium phosphate administered in a fixed-dose regimen in critically ill patients. " 06/01/1997 - "The administration of potassium phosphate 15 mmol to critically ill patients with mild-to-moderate hypophosphatemia over 3 hours is both effective and safe. " 12/01/2002 - "Acute hypophosphataemia may present with paraesthasia, confusion, seizures, weakness, hypotension and heart failure and in the critically ill requires intravenous sodium or potassium phosphate. " 03/01/2001 - "While isotonic saline solutions are used to improve the haemodynamic status in critically ill patients who are hypotensive and hypovolaemic, other intravenous solutions including potassium chloride, calcium chloride, magnesium sulphate and sodium or potassium phosphate as well as hypertonic saline and sodium bicabonate have unique and often therapeutically useful haemodynamic and antiarrhythmic effects. "
3.	Osteomalacia 12/01/2014 - "This report describes a case of severe hypophosphatemic osteomalacia with multiple fragility fractures induced by adefovir, which was worsened and confounded by a previous treatment with zoledronic acid and required prolonged intravenous potassium phosphate administration. " 01/01/2015 - "After administration of 1,25 dihydroxyvitamin D3, neutral potassium phosphate, sodium bicarbonate for osteomalacia and subsequent predonizolone for TIN, symptoms of fractures were relieved and renal function including Fanconi syndrome was ameliorated. "
4.	Infection 02/01/2004 - "In laboratory tests, treatment of the first leaves of barley (Hordeum vulgare L cv Golden Promise) with potassium phosphate led to significant reduction in infection of the second leaves with the powdery mildew fungus Blumeria graminis f sp hordei Marchal, with a 25 mM treatment giving 89% reduction in infection. " 02/01/2004 - "Protection against powdery mildew infection was not as effective when the potassium phosphate was applied as a seed treatment or root drench. " 02/01/2004 - "Potassium phosphate induces systemic protection in barley to powdery mildew infection." 07/01/1977 - "Optimum conditions for encystment included infection of stationary-phase prey cells in 0.05 M potassium phosphate buffer (pH 7.5) at concentrations of prey and bdellovibrios of 2 X 10(9) cells per ml with a multiplicity of infection of unity. "
5.	Pulmonary Hypertension (Ayerza Syndrome) 01/01/2006 - "In the intensive care unit he initially improved but developed severe hypoxaemia, right ventricular failure and pulmonary hypertension 90 min after receiving intravenous calcium gluconate and potassium phosphate, best explained by the formation of a calcium-phosphate precipitant that resulted in aggregate anaphylaxis. "

Related Drugs and Biologics

1.	Sodium Bicarbonate (Baking Soda)
2.	Potassium
3.	Magnesium
4.	Sodium
5.	Potassium Chloride
6.	Calcium Gluconate (CBG)
7.	calcium phosphate
8.	Tin
9.	Calcium Chloride (Calcium Chloride, Anhydrous)
10.	Calcitriol (Calcijex)

Related Therapies and Procedures

1.	Intravenous Injections
2.	Drug Therapy (Chemotherapy)
3.	Bed Rest (Bedrest)
4.	Oral Administration